These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 35186378)

  • 1. An Imported Case of BA.2 Lineage of Omicron Variant COVID-19 - Guangdong Province, China, December 28, 2021.
    Guo Q; A R; Liang L; Zhao X; Deng A; Hu Y; Zheng Z; Zou L; Chen C; Li B
    China CDC Wkly; 2022 Feb; 4(5):98-99. PubMed ID: 35186378
    [No Abstract]   [Full Text] [Related]  

  • 2. An Imported Case and an Infected Close Contact of the Omicron Variant of SARS-CoV-2 - Guangdong Province, China, December 13, 2021.
    Li K; Zheng Z; Zhao X; Zeng Q; Zhou T; Guo Q; Hu Y; Xu W; Zhang Z; Li B
    China CDC Wkly; 2022 Feb; 4(5):96-97. PubMed ID: 35186377
    [No Abstract]   [Full Text] [Related]  

  • 3. First Imported Case of SARS-CoV-2 Omicron Subvariant BA.2.12.1 - Guangdong Province, China, April 30, 2022.
    Liang L; Zhao X; Deng A; Li K; Liu J; Ouyang F; Guo Q; Xu J; Huang S; Zou L; Song Y; Nie K; Li B
    China CDC Wkly; 2022 Aug; 4(31):693-694. PubMed ID: 36059790
    [No Abstract]   [Full Text] [Related]  

  • 4. First Imported Case of SARS-CoV-2 Omicron Subvariant BA.4 - Guangdong Province, China, May 4, 2022.
    Guo Q; Wu C; Deng A; Liang J; Zhao X; A R; Liu J; Ouyang F; Xu J; Huang S; Song Y; Zou L; Deng X; Nie K; Li B
    China CDC Wkly; 2022 Oct; 4(40):902-903. PubMed ID: 36285320
    [No Abstract]   [Full Text] [Related]  

  • 5. An Outbreak of the SARS-CoV-2 Omicron Variant BA.1 - Zhuhai City, Guangdong Province, China, January 13, 2022.
    Ruan F; Zhang X; Xiao S; Ni X; Yin X; Ye Z; Chen G; Zhu T; Chen Z; Yao G; Chen L; Huang S; Huang H; Zhou Y; Wu H; Huang H; Zhu K; Huang S; Tang X; Kang M; Li B; Mei W
    China CDC Wkly; 2022 Jul; 4(30):669-671. PubMed ID: 36062072
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risk assessment and early warning of imported COVID-19 in Guangdong province].
    Hu JX; Liu T; Xiao JP; He GH; Rong ZH; Yin LH; Wan DH; Zeng WL; Gong DX; Guo LC; Zhu ZH; Zeng LL; Kang M; Song T; Zhong HJ; He JF; Sun LM; Li Y; Ma WJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):657-661. PubMed ID: 32213268
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interval between entry of mainland China and diagnosis in imported COVID-19 cases and factors contributing to delayed diagnosis in Guangdong Province].
    Cheng L; Xu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):741-745. PubMed ID: 32897209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The First Two Imported Cases of SARS-CoV-2 Omicron Variant - Tianjin Municipality, China, December 13, 2021.
    Tan Z; Chen Z; Yu A; Li X; Feng Y; Zhao X; Xu W; Su X
    China CDC Wkly; 2022 Jan; 4(4):76-77. PubMed ID: 35186373
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical Care Response to the Outbreak of COVID-19: The Experience From Guangdong Province, China.
    Liu X; Xu Y; Xu Z; Xu Y; He W; Huang Y; Zhong N; Qin T; Li Y
    Front Public Health; 2020; 8():576528. PubMed ID: 33262968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Imported Cases of New Variant COVID-19 First Emerging from Brazil - Guangdong Province, China, April 30, 2021.
    Hu Y; Zhao X; Song Y; Li Z; Kang M; Deng X; Li B
    China CDC Wkly; 2021 May; 3(21):456-458. PubMed ID: 34594912
    [No Abstract]   [Full Text] [Related]  

  • 12. Two Imported Cases of New Variant COVID-19 First Emerging in Nigeria - Guangdong Province, China, March 12, 2021.
    Hu Y; Zhao X; Li Z; Kang M; Deng X; Li B
    China CDC Wkly; 2021 May; 3(19):411-413. PubMed ID: 34594896
    [No Abstract]   [Full Text] [Related]  

  • 13. The epidemiological characteristics of dengue in high-risk areas of China, 2013-2016.
    Sang S; Liu Q; Guo X; Wu D; Ke C; Liu-Helmersson J; Jiang J; Weng Y; Wang Y
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009970. PubMed ID: 34928951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.
    Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y
    Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological analysis of malaria epidemic situation in Guangdong Province, 2011].
    Pan B; Ruan CW; Lin RX; Pei FQ; Zhang QM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Feb; 25(1):40-3. PubMed ID: 23687810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021.
    Gu H; Krishnan P; Ng DYM; Chang LDJ; Liu GYZ; Cheng SSM; Hui MMY; Fan MCY; Wan JHL; Lau LHK; Cowling BJ; Peiris M; Poon LLM
    Emerg Infect Dis; 2022 Feb; 28(2):460-462. PubMed ID: 34860154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022.
    Song P; Karako T
    Biosci Trends; 2022 Jan; 15(6):350-352. PubMed ID: 34980786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring utility of genomic epidemiology to trace origins of highly pathogenic influenza A/H7N9 in Guangdong.
    Bai R; Sikkema RS; Munnink BBO; Li CR; Wu J; Zou L; Jing Y; Lu J; Yuan RY; Liao M; Koopmans M; Ke CW
    Virus Evol; 2020 Jul; 6(2):veaa097. PubMed ID: 33391821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Returning ex-patriot Chinese to Guangdong, China, increase the risk for local transmission of Zika virus.
    Sun J; Wu D; Zhong H; Guan D; Zhang H; Tan Q; Zhou H; Zhang M; Ning D; Zhang B; Ke C; Song T; Lin J; Zhang Y; Koopmans M; Gao GF
    J Infect; 2017 Oct; 75(4):356-367. PubMed ID: 28712937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.